Schizophrenia Prescriber Audiences
Reach the 126,187 physicians who treat schizophrenia by NPI, at home and across devices, with results reported every week. At $1.50 to $3.00 CPM, these audiences are priced at approximately 50% or less of the market rate.
Qualified audience
Every household and prescriber is scored 0 to 100 for fit to this condition. You buy only the tiers that qualify.
$1.50 to $3.00 CPM
Priced at approximately 50% or less of the market rate for pharma audiences.
Weekly measurement
Qualified reach, lift against the national baseline, and reach by state, reported every week.
Patients · DTC panel reach
For schizophrenia, we lead with prescriber targeting. The strictest patient tier did not beat the national baseline in our last test, so we don't make a patient lift claim here.
- High-fit people, national (score 73+)
- 4.4M
- Qualified people, national (score 61+)
- 55.3M
- Digitally active, qualified
- 12.3M
Prescribers · HCP active Type 1 NPIs
| Specialty | NPIs | At home |
|---|---|---|
| Treating | 126,187 | 72,246 |
| Psychiatry | 126,187 | 72,246 |
| Referring | 327,135 | 200,836 |
| Family & internal medicine | 327,135 | 200,836 |
| Total prescribers | 453,322 | 273,082 |
Counted by primary NUCC taxonomy in the CMS NPPES registry (September 2026). "At home" means matched to a home address in Semcasting's NPI file, for reach on CTV, streaming and display. Referring counts exclude doctors already counted as treating.
Where qualified patients concentrate top states by share
- New Mexico
- Texas
- Arkansas
- Alabama
- Georgia
- Louisiana
Common questions
How many prescribers treat schizophrenia?
126,187 active Type 1 NPIs in the treating specialties (psychiatry), 72,246 of them matched to a home address for CTV, streaming and display. Another 327,135 referring prescribers are counted separately. Counts come from the CMS NPPES registry, September 2026.
Why lead with prescriber targeting for schizophrenia?
The strictest patient tier for schizophrenia did not beat the national baseline in the last Audience Quality Test, so Semcasting makes no patient lift claim here. Prescriber targeting by NPI, at home and across devices, is the recommended approach.
Does the schizophrenia audience use diagnosis, claims or prescription data?
No. Patient audiences are built from peer-reviewed, population-level public health reporting and population surveys, scored against Semcasting's national adult file. No diagnosis records, claims, prescriptions or PHI are used, and the score says nothing about any one person's health.
Evidence base primary sources for schizophrenia
- Federal public healthNIH National Institute of Mental Health
- Population surveySAMHSA National Survey on Drug Use and Health
How the audience is built
Patient counts for schizophrenia come from physician-reported registries, diagnostic population surveys, and federal (CDC, CMS, NIH) and disease-association reporting, listed above. Each of 251.7M U.S. adult records is scored 0 to 100 for fit to those published patient profiles by age, gender and income. No published geographic breakdown meets our standard for this condition, so it is scored on demographic fit alone. Qualified means a score of 61 or higher. High-fit means 73 or higher.
How quality is confirmed
Audience quality has historically been confirmed through holdout sampling: a delivered audience is compared with the full national panel at the same fixed score cutoffs, and the difference is reported as lift. During a campaign, the same comparison runs every week on the households actually reached.
What it is not
Qualified audiences are not built from modeled claims data extrapolated from a few locations. They come from peer-reviewed, population-level public health reporting on patient profiles and population surveys. No diagnosis records, claims, prescriptions or PHI are used, and the score says nothing about any one person's health.